Clinical characteristics, treatment options, and prognosis of myeloid sarcoma: analysis using the SEER database.
Hematology (Amsterdam, Netherlands)(2023)
摘要
Early combination therapy in IMS patients had a longer OS, and chemotherapy combined with radiotherapy/surgery should be the treatment of choice. For non-IMS patients, early combination therapy did not show a significant advantage. Age and location of first presentation were independent factors affecting MS patients' long-term prognosis.
更多查看译文
关键词
myeloid sarcoma, treatment, SEER, overall survival, prognostic factors, >
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要